US 10398661
Methods for classifying a cancer as susceptible to TMEPAI-directed therapies and treating such cancers
granted A61KA61K2039/505A61K31/19
Quick answer
US patent 10398661 (Methods for classifying a cancer as susceptible to TMEPAI-directed therapies and treating such cancers) held by The Board of Regents of the University of Texas System expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/505, A61K31/19, A61K45/06, A61P